Delivery Order SPE2DB22D2206-SPE2DB25FJA16
Award Date 7/22/25
Potential Completion Date 8/12/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of 100 mg vials of Enhertu, a prescription oncology medication, with a ceiling value of $7,110.80. This firm fixed-price contract, which is not set-aside, has an ultimate completion date of August 18, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, valued at $8,888.50 with a firm fixed price arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $17,777 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a HER2-directed antibody-drug conjugate used in oncology treatment. This non-set-aside competitive award, issued on July 25, 2025, is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...
- This delivery order, valued at $17,777, was awarded on July 22, 2025, to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials under a firm fixed-price arrangement. The contract is a non-set-aside award issued by the Medical Supply Chain, a Defense-focused federal agency, with a completion deadline of August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- This is a $16,117.70 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Enhertu 100 mg vials, a specialty pharmaceutical product, with a performance period through August 28, 2024. Amerisourcebergen is a leading pharmaceutical distributor that holds multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG vials. The delivery order, valued at $19,341.24, is a firm-fixed-price contract with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a $17,777.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG VIALS. The contract has an ultimate completion date of July 23, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $21,614.96 award is for the provision of ENHERTU 100 MG vials, a specialty pharmaceutical product, with a completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,777.00 firm fixed price contract is for ENHERTU 100 MG VIALS, a medication, with a period of performance through February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...